BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30849607)

  • 1. Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives.
    Taieb J; André T; Auclin E
    Cancer Treat Rev; 2019 May; 75():1-11. PubMed ID: 30849607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy in colon cancer--what, when and how?
    Chau I; Cunningham D
    Ann Oncol; 2006 Sep; 17(9):1347-59. PubMed ID: 16524974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
    Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
    PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry.
    Park YS; Ji J; Zalcberg JR; El-Serafi M; Buzaid A; Ghosn M
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):334-42. PubMed ID: 26471890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluoropyrimidines with oxaliplatin(L-OHP) as an adjuvant chemotherapy for Stage III colon cancer].
    Miyake Y; Ikeda K; Osawa H; Nagase H; Hoshi M; Doi T; Makari Y; Oshima S; Iijima S; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2161-3. PubMed ID: 23268010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant therapy for colon cancer].
    Fey MF
    Schweiz Med Wochenschr; 2000 Nov; 130(46):1760-5. PubMed ID: 11127955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy in colon cancer: current status and future directions.
    Chau I; Cunningham D
    Cancer Treat Rev; 2002 Oct; 28(5):223-36. PubMed ID: 12435370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.
    Meyers BM; Cosby R; Quereshy F; Jonker D
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):459-465. PubMed ID: 28341242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.
    Auclin E; Zaanan A; Vernerey D; Douard R; Gallois C; Laurent-Puig P; Bonnetain F; Taieb J
    Ann Oncol; 2017 May; 28(5):958-968. PubMed ID: 28453690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
    Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
    Medinger M; Steinbild S; Mross K
    Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
    Formica V; Zaniboni A; Loupakis F; Roselli M
    Int J Cancer; 2018 Nov; 143(10):2342-2350. PubMed ID: 29873066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant colon cancer chemotherapy: where we are and where we'll go.
    Lombardi L; Morelli F; Cinieri S; Santini D; Silvestris N; Fazio N; Orlando L; Tonini G; Colucci G; Maiello E
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S34-41. PubMed ID: 21129608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
    Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
    Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in stage II colon cancer: current approaches.
    Baddi L; Benson A
    Oncologist; 2005 May; 10(5):325-31. PubMed ID: 15851790
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and methods for adjuvant chemotherapy of colonic cancer].
    Louvet C
    Pathol Biol (Paris); 2004 Apr; 52(3):119-22. PubMed ID: 15063929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progression of adjuvant chemotherapy for colon cancer].
    He YJ; Dong QM; Li YH
    Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.